Cargando…

Self-Sampling for Human Papillomavirus Testing among Non-Attenders Increases Attendance to the Norwegian Cervical Cancer Screening Programme

Increasing attendance to screening offers the best potential for improving the effectiveness of well-established cervical cancer screening programs. Self-sampling at home for human papillomavirus (HPV) testing as an alternative to a clinical sampling can be a useful policy to increase attendance. To...

Descripción completa

Detalles Bibliográficos
Autores principales:	Enerly, Espen, Bonde, Jesper, Schee, Kristina, Pedersen, Helle, Lönnberg, Stefan, Nygård, Mari
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4830596/ https://www.ncbi.nlm.nih.gov/pubmed/27073929 http://dx.doi.org/10.1371/journal.pone.0151978

Ejemplares similares

Monitoring human papillomavirus prevalence in urine samples: a review
por: Enerly, Espen, et al.
Publicado: (2013)

Factors associated with non-attendance, opportunistic attendance and reminded attendance to cervical screening in an organized screening program: a cross-sectional study of 12,058 Norwegian women
por: Hansen, Bo T, et al.
Publicado: (2011)

High-grade cervical intraepithelial neoplasia in human papillomavirus self-sampling of screening non-attenders
por: Lam, J U H, et al.
Publicado: (2018)

The BD Onclarity HPV Assay on Samples Collected in SurePath Medium Meets the International Guidelines for Human Papillomavirus Test Requirements for Cervical Screening
por: Ejegod, Ditte, et al.
Publicado: (2016)

Cervical cancer mortality in Norway according to screening attendance and age
por: Baasland, Ingrid, et al.
Publicado: (2022)

Comparative effectiveness study on human papillomavirus detection methods used in the cervical cancer screening programme
por: Nygård, Mari, et al.
Publicado: (2014)

Frequency of Human papillomavirus in women attending cervical cancer screening program in Chile
por: Brebi, Priscilla, et al.
Publicado: (2017)

Perspectives of non-attenders for cervical cancer screening in Norway: a qualitative focus group study
por: Aasbø, Gunvor, et al.
Publicado: (2019)

Time and temperature dependent analytical stability of dry-collected Evalyn HPV self-sampling brush for cervical cancer screening
por: Ejegod, Ditte Møller, et al.
Publicado: (2018)

Human papillomavirus testing in primary cervical screening and the cut-off level for hybrid capture 2 tests: systematic review
por: Rebolj, Matejka, et al.
Publicado: (2011)

Impact of the Mobile Game FightHPV on Cervical Cancer Screening Attendance: Retrospective Cohort Study
por: Orumaa, Madleen, et al.
Publicado: (2022)

Human papillomavirus infection in women attended at a cervical cancer screening service in Natal, Brazil
por: de Medeiros Fernandes, Thales Allyrio Araújo, et al.
Publicado: (2008)

Type- and age-specific distribution of human papillomavirus in women attending cervical cancer screening in Finland
por: Leinonen, M K, et al.
Publicado: (2013)

Randomised Trial of HPV Self-sampling Among Non-attenders in the Slovenian Cervical Screening Programme ZORA: Comparing Three Different Screening Approaches
por: Ivanus, Urska, et al.
Publicado: (2018)

Human papillomavirus self‐sampling for screening nonattenders: Opt‐in pilot implementation with electronic communication platforms
por: Lam, Janni Uyen Hoa, et al.
Publicado: (2017)

Cervical cancer screening programme attendance and compliance predictors regarding Colombia’s Amazon region
por: González, Alejandra, et al.
Publicado: (2022)

Clinical and Analytical Performance of the BD Onclarity HPV Assay with SurePath Screening Samples from the Danish Cervical Screening Program Using the VALGENT Framework
por: Bonde, Jesper Hansen, et al.
Publicado: (2020)

The burden of hospital-attended influenza in Norwegian children
por: Bøås, Håkon, et al.
Publicado: (2022)

HPV self-sampling among long-term non-attenders to cervical cancer screening in Norway: a pragmatic randomised controlled trial
por: Aasbø, Gunvor, et al.
Publicado: (2022)

Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the international guidelines for human papillomavirus test requirements for cervical screening
por: Ejegod, Ditte Møller, et al.
Publicado: (2020)

Organized screening programmes for breast and cervical cancer in 17 EU countries: trajectories of attendance rates
por: Gianino, Maria Michela, et al.
Publicado: (2018)

Agreement between Self- and PhysicianSampling for Detection of HighRisk Human Papillomavirus Infections in Women Attending Cervical Screening at National Cancer Institute, Thailand
por: Sangrajrang, Suleeporn, et al.
Publicado: (2023)

Clinical Utility of Human Papillomavirus Genotyping in Cervical Cancer Screening: A Systematic Review
por: Bonde, Jesper H., et al.
Publicado: (2019)

Colposcopy attendance and deprivation: A retrospective analysis of 27 193 women in the NHS Cervical Screening Programme
por: Douglas, E, et al.
Publicado: (2015)

Women's perspectives on human papillomavirus self‐sampling in the context of the UK cervical screening programme
por: Williams, Denitza, et al.
Publicado: (2017)

Human papillomavirus detection in cervical scrapes from women attended in the Family Health Program
por: Augusto, Everton Faccini, et al.
Publicado: (2014)

Human papillomavirus prevalence in women attending routine cervical screening in South Wales, UK: a cross-sectional study
por: Hibbitts, S, et al.
Publicado: (2008)

Clinical Validation of the Onclarity Assay After Assay Migration to the High-Throughput COR Instrument Using SurePath Screening Samples From the Danish Cervical Cancer Screening Program
por: Ejegod, Ditte Møller, et al.
Publicado: (2021)

Knowledge of Cervical Cancer Screening and Prevention by Human Papillomavirus Deoxyribonucleic Acid and Human Papillomavirus Vaccination among Women Attending a Tertiary Care Centre
por: Vaidya, Sapana Amatya, et al.
Publicado: (2023)

When Life Got in the Way: How Danish and Norwegian Immigrant Women in Sweden Reason about Cervical Screening and Why They Postpone Attendance
por: Azerkan, Fatima, et al.
Publicado: (2015)

The characteristics of women not-attending screening and their barriers to attendance in Czechia
por: Altová, A, et al.
Publicado: (2022)

Human Papillomavirus Assays and Cytology in Primary Cervical Screening of Women Aged 30 Years and Above
por: Rebolj, Matejka, et al.
Publicado: (2016)

Disagreement between Human Papillomavirus Assays: An Unexpected Challenge for the Choice of an Assay in Primary Cervical Screening
por: Rebolj, Matejka, et al.
Publicado: (2014)

Long Term Results of Follow-up After HPV Self-sampling with Devices Qvintip and HerSwab in Women Non-attending Cervical Screening Programme
por: Bokan, Teodora, et al.
Publicado: (2021)

Performance of the Xpert HPV assay in women attending for cervical screening
por: Cuzick, Jack, et al.
Publicado: (2015)

The effect of extended participation windows on attendance at cervical cancer screening
por: Castañeda, Kelly M., et al.
Publicado: (2023)

Does the primary screening test influence women’s anxiety and intention to screen for cervical cancer? A randomized survey of Norwegian women
por: Burger, Emily A, et al.
Publicado: (2014)

HPV self-sampling as an alternative strategy in non-attenders for cervical screening – a randomised controlled trial
por: Szarewski, A, et al.
Publicado: (2011)

Determinants of (non-)attendance at the Dutch cancer screening programmes: A systematic review
por: Bongaerts, Thomas HG, et al.
Publicado: (2019)

Knowledge of Human Papillomavirus and Cervical Cancer among Women Attending Gynecology Clinics in Pretoria, South Africa
por: Tiiti, Teboho Amelia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g7jhth2c8qm2c54d40plos6sq7